miR-181a initiates and perpetuates oncogenic transformation through the regulation of innate immune signaling
出版年份 2020 全文链接
标题
miR-181a initiates and perpetuates oncogenic transformation through the regulation of innate immune signaling
作者
关键词
-
出版物
Nature Communications
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-06-26
DOI
10.1038/s41467-020-17030-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A miRNA-Mediated Approach to Dissect the Complexity of Tumor-Initiating Cell Function and Identify miRNA-Targeting Drugs
- (2019) Anil Belur Nagaraj et al. Stem Cell Reports
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- The cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer
- (2018) Tuo Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts
- (2017) Renier Vélez-Cruz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease
- (2017) Yali Zhai et al. JOURNAL OF PATHOLOGY
- Nuclear Envelope Rupture Is Enhanced by Loss of p53 or Rb
- (2017) Zhe Yang et al. MOLECULAR CANCER RESEARCH
- cGAS surveillance of micronuclei links genome instability to innate immunity
- (2017) Karen J. Mackenzie et al. NATURE
- Mitotic progression following DNA damage enables pattern recognition within micronuclei
- (2017) Shane M. Harding et al. NATURE
- RB localizes to DNA double-strand breaks and promotes DNA end resection and homologous recombination through the recruitment of BRG1
- (2016) Renier Vélez-Cruz et al. GENES & DEVELOPMENT
- RB1: a prototype tumor suppressor and an enigma
- (2016) Nicholas J. Dyson GENES & DEVELOPMENT
- Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
- (2016) Eileen E. Parkes et al. JNCI-Journal of the National Cancer Institute
- Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube
- (2016) M. A. Eckert et al. Cancer Discovery
- Genome Stability Requires p53
- (2016) Christine M. Eischen Cold Spring Harbor Perspectives in Medicine
- Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
- (2016) Eileen E. Parkes et al. JNCI-Journal of the National Cancer Institute
- YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells
- (2015) G Hua et al. ONCOGENE
- Interferons and the Immunogenic Effects of Cancer Therapy
- (2015) Andy J. Minn TRENDS IN IMMUNOLOGY
- Copy number variations are progressively associated with the pathogenesis of colorectal cancer in ulcerative colitis
- (2015) Bhadravathi Marigowda Shivakumar WORLD JOURNAL OF GASTROENTEROLOGY
- Tracking the Genomic Evolution of Esophageal Adenocarcinoma through Neoadjuvant Chemotherapy
- (2015) N. Murugaesu et al. Cancer Discovery
- RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy
- (2015) Paola Indovina et al. Oncotarget
- Role of miR-182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells
- (2015) Yugang Liu et al. Oncotarget
- Molecular Requirements for Transformation of Fallopian Tube Epithelial Cells into Serous Carcinoma
- (2015) Amir A. Jazaeri et al. NEOPLASIA
- Clonal evolution in breast cancer revealed by single nucleus genome sequencing
- (2014) Yong Wang et al. NATURE
- microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition
- (2014) Aditya Parikh et al. Nature Communications
- Origin and Pathogenesis of Pelvic (Ovarian, Tubal, and Primary Peritoneal) Serous Carcinoma
- (2013) Niloofar N. Nik et al. Annual Review of Pathology-Mechanisms of Disease
- Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube-Derived High-Grade Serous Ovarian Cancers
- (2013) A. M. Karst et al. CANCER RESEARCH
- Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
- (2013) Ali Bashashati et al. JOURNAL OF PATHOLOGY
- miR-181a and inflammation: miRNA homeostasis response to inflammatory stimuli in vivo
- (2012) Weidong Xie et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications
- (2012) Weiwei Shan et al. CELL CYCLE
- microRNA-181a represses ox-LDL-stimulated inflammatory response in dendritic cell by targeting c-Fos
- (2012) Chaoneng Wu et al. JOURNAL OF LIPID RESEARCH
- MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma
- (2012) Zhaojian Liu et al. JOURNAL OF PATHOLOGY
- Primary culture and immortalization of human fallopian tube secretory epithelial cells
- (2012) Alison M Karst et al. Nature Protocols
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Mitotic Defects Lead to Pervasive Aneuploidy and Accompany Loss of RB1 Activity in Mouse LmnaDhe Dermal Fibroblasts
- (2011) C. Herbert Pratt et al. PLoS One
- Modeling high-grade serous ovarian carcinogenesis from the fallopian tube
- (2011) A. M. Karst et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Loss of pRB causes centromere dysfunction and chromosomal instability
- (2010) A. L. Manning et al. GENES & DEVELOPMENT
- PML Nuclear Bodies
- (2010) V. Lallemand-Breitenbach et al. Cold Spring Harbor Perspectives in Biology
- Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics
- (2010) Amy L. Gross et al. Journal of Oncology
- RNAi mediated acute depletion of Retinoblastoma protein (pRb) promotes aneuploidy in human primary cells via micronuclei formation
- (2009) Angela Amato et al. BMC CELL BIOLOGY
- A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations
- (2008) Ann K. Folkins et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now